Why the study?
The role of cystatin C-based estimations of kidney function in acutely ill, hospitalized patients has not been fully established.
Is there a significant discordance between combined serum creatinine/cystatin C-based and serum creatinine-based estimations of kidney function in acutely ill hospitalized patients?
Is there a significant discordance between combined serum creatinine/cystatin C-based and serum creatinine-based estimations of kidney function in acutely ill hospitalized patients?
In hospitalized patients, combined serum creatinine and cystatin C-based eGFR estimates are discordant with Cockcroft-Gault estimates in over 40% of cases, particularly in critically ill patients, which may significantly impact drug dosing.
CysC-based eGFR may refine dosing accuracy in hospitalized patients with SCr discordance; leaves open outcome impact in prospective trials.
Introduction: Traditional estimations of kidney function relying on serum creatinine (SCr) have significant limitations, as SCr is affected by many non-kidney determinants, such as body composition, age, nutritional status, volume status, etc. While cystatin C (cysC) is not without its own limitations, support for cysC use as an alternative or additional method of kidney function assessment is developing. The role of cysC-based estimations of kidney function in acutely ill, hospitalized patients has not been fully established. Objective: The objective of this study was to determine the incidence of discordance in estimated glomerular filtration rate (eGFR) between SCr-based calculations and SCr/cysC-based calculations of kidney function. Methods: This was a single-center, retrospective, observational cohort study at an academic medical center including adult inpatients admitted in 2023 with SCr and CysC ordered. The primary outcome was discordance, defined as an occurrence of a 30% or greater difference between Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) eGFR SCr-cysC (eGFRcr-cys) and Cockcroft Gault (CG). Data was collected via chart review. Descriptive statistics were used. Nominal data (%) was analyzed by Fisher’s exact test and continuous data (median [IQR]), including discordance, was analyzed via Wilcoxon matched pair signed ranked sum. For comparison, eGFRcr-cys was individualized for patients’ body surface area. Results: The study included 463 patients (49% female, age 61 [48-72] years, 50.1% critically ill) with SCr 1.14 [0.68-1.82] mg/dL and cysC 2.00 [1.33-2.78] g/dL. Clearance was 60.0 [34.0-100.5] mL/min by CG and 43.0 [24.5-71.0] mL/min by eGFRcr-cys. Discordance rate was 44.3% (205/463). Compared to patients without discordance, patients with discordance were younger (55 years [44-65] vs 65 years [55-74]; P < .001) and had lower median SCr (0.93 mg/dL [0.48-1.58] vs 1.35 mg/dL [0.85-2.10], P < .001). Discordance occurred more often in critically ill patients (52.2%; 121/232 patients) than general medicine/surgical patients (36.4%; 84/231 patients, P < .001). Conclusion: In hospitalized patients, eGFRcr-cys was discordant with CG in 44.3% of the population. Discordance in kidney function estimates likely impacts clinical care, including drug dosing. Further studies are needed to determine optimal use of each estimation.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: